Training requirements for residential care workers vary dramatically across the nation, a new report finds. Ten states have no rules on the books.
A temporary reprieve?
By
John O'Connor
Dec 01, 2016
A new federal rule that would have disallowed arbitration agreements during resident admissions has been put on hold, at least for now.
McKnight’s 40 for 40: Sheldon L. Goldberg
By
John O'Connor
Sep 08, 2020
Sheldon Goldberg’s time at the helm of the organization now known as LeadingAge aligns with some of the more challenging years the industry has ever faced.
Memo to memory care communities: Don’t bogart that medicine, and lighten up
By
John O'Connor
Jul 25, 2018
Could synthetic marijuana and bright lights be the next big things in dementia care? New findings revealed at the Alzheimer’s Association’s International Conference in Chicago suggest both...
Lawmaker seeks expanded Medigap coverage for senior living
By
John O'Connor
Jun 05, 2019
A leading House Democrat is seeking ways to get more senior living services covered by Medigap insurance policies.
Statins may help reduce risk for Alzheimer’s disease
By
John O'Connor
Dec 14, 2016
Drugs frequently prescribed to treat high cholesterol might also help reduce the odds a person will suffer from Alzheimer’s disease, a new examination of Medicare data has found.
Alzheimer’s finding a real eye-opener
By
John O'Connor
Aug 01, 2015
Extra sleep can help fruit flies overcome Alzheimer’s disease-like memory problems, according to new research out of Washington University School of Medicine in St. Louis.
NIC speakers: Good fit is key going forward
By
John O'Connor
Mar 10, 2016
The secret to success in senior living may be as simple and as difficult as finding the right fit, according to speakers at the 2016 NIC Spring Investment Forum.
Napping may be a sign of approaching Alzheimer’s
By
John O'Connor
Aug 13, 2019
When residents begin to take more naps, it might not just be that they are tired. New research indicates it might be an early warning sign of advancing Alzheimer’s disease.
Bill Gates sets aside $100 million for Alzheimer’s research
By
John O'Connor
Nov 14, 2017
Billionaire Bill Gates announced he will invest $50 million in the Dementia Discovery Fund. The venture capital fund links targets the disease by coordinating public and private-sector efforts.